Home      About this journal      Authors      Editors      Readers      Archive      Contact us
A Meta-analysis of randomized controlled clinical study on treating irritable bowel syndrome with modified Chaihu Shugan powder
Hits 1652  Download times 1456    
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2017.12.04
Key Words   Chaihu Shugan powder;irritable bowel syndrome;randomized controlled trial;Meta-analysis
Author NameAffiliationE-mail
SU Kai-qi Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China  
SHEN Yan-ting Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China  
LIN Liu-bing Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China  
QUE Ren-ye Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China  
CHEN Yi-rong Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China  
LI Yong Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China liyong_sci@126.com 
Abstract
    [Objective] To evaluate the clinical efficacy and safety of Chaihu Shugan powder in the treatment of irritable bowel syndrome (IBS).[Methods] CNKI, CBM, VIP and Wanfang data, PubMed, The Cochrane Library, Embase were searched for the randomized controlled clinical trials of all Chaihu Shugan powder in the treatment of irritable bowel syndrome, and the time was set from the time when the database was created to October 10, 2016. Meta-analysis was carried out by RevMan 5.3 software, which was used to evaluate the quality of the method and extract valid data.[Results] Eleven studies were eventually included and included a total of 1 288 patients. Meta-analysis showed that Chaihu Shugan powder could significantly improve the total effective rate, markedly effective rate and cure rate in IBS, compared with conventional Western medicine treatment. Total effective rate[OR=4.98, 95% CI(3.56, 6.96), P<0.000 01], cure rate[OR=2.19,95% CI(1.49,3.20), P<0.000 1], significantly effective rate[OR=1.84, 95% CI(1.40, 2.41), P<0.000 1]. And no significant reactions were found.[Conclusion] Chaihu Shugan powder has better clinical efficacy than routine Western medicine in the treatment of irritable bowel syndrome. However, considering that the quality of the literatures is low, there may be a high risk of bias. So more designs contain a large sample of clinical trials are needed in the hope that we can provide a more reliable clinical evidence-based medicine.

You are the 2308642 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.